- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 159.88M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 161.9M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 159.9M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $30.1M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $49.6M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $9.1M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $557.3M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $579.7M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $2.59B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $2.55B |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.43B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.4B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $6.23B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $5.31B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $6.91B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $6.57B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $6.36B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $5.98B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $9.5B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $9.12B |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.09 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.04 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | $0.09 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.05 |
| Net Income | Q1 2025 · Mar 31, 2025 | $14.9M |
| Net Income | Q1 2025 · Mar 31, 2024 | $7.1M |
| Operating Income | Q1 2025 · Mar 31, 2025 | $31M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $40.7M |
| Revenue | Q1 2025 · Mar 31, 2025 | $481.8M |
| Revenue | Q1 2025 · Mar 31, 2024 | $431.5M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $18.5M |